Medicare IVIG Access Enhancement Act of 2023

Hozzl · 2024-12-19T09:05:19Z

Explore the details of House Bill 5818 Medicare IVIG Access Enhancement Act of 2023 currently in Congress. Get insights into its purpose, current status, sponsors, and potential impact on Health. Stay informed on legislative developments.

12/19/2024, 9:05 AM

Summary of Bill HR 5818

The Medicare IVIG Access Enhancement Act of 2023, also known as Bill 118 hr 5818, aims to improve access to Intravenous Immunoglobulin (IVIG) for Medicare beneficiaries. IVIG is a treatment used for various autoimmune and inflammatory conditions, but access to this treatment can be limited due to high costs and administrative barriers.

This bill seeks to address these issues by establishing a demonstration project that would provide coverage for IVIG for Medicare beneficiaries in both inpatient and outpatient settings. The goal of this project is to evaluate the effectiveness of providing coverage for IVIG and determine the impact on patient outcomes and healthcare costs.

Additionally, the bill includes provisions to streamline the process for prescribing and administering IVIG, as well as measures to improve coordination of care for patients receiving this treatment. It also calls for increased education and training for healthcare providers on the use of IVIG. Overall, the Medicare IVIG Access Enhancement Act of 2023 aims to improve access to IVIG for Medicare beneficiaries, with the ultimate goal of improving patient outcomes and reducing healthcare costs.

Read the Full Bill

Formatted Text PDF Formatted XML

Current Status of Bill HR 5818

Bill HR 5818 is currently in the status of Bill Introduced since September 28, 2023. Bill HR 5818 was introduced during Congress 118 and was introduced to the House on September 28, 2023. Bill HR 5818's most recent activity was Referred to the Subcommittee on Health. as of December 17, 2024

Bipartisan Support of Bill HR 5818

Total Number of Sponsors

Democrat Sponsors

Republican Sponsors

Unaffiliated Sponsors

Total Number of Cosponsors

Democrat Cosponsors

Republican Cosponsors

Unaffiliated Cosponsors

Policy Area and Potential Impact of Bill HR 5818

Primary Policy Focus

Health

Alternate Title(s) of Bill HR 5818

Medicare IVIG Access Enhancement Act of 2023

To amend title XVIII of the Social Security Act to expand coverage of the in-home administration of intravenous immune globulin under the Medicare program.